Skeletal muscle endurance training improves peripheral oxidative capacity, exercise tolerance, and health-related quality of life in women with chronic congestive heart failure secondary to either ischemic cardiomyopathy or idiopathic dilated cardiomyopathy

https://doi.org/10.1016/S0002-9149(97)00597-3Get rights and content

Abstract

Despite reported benefits of exercise training in men with chronic congestive heart failure (CHF) and in both men and women with coronary artery disease, the effects of training in women with CHF have not been throughly investigated. Therefore, 16 women (62 ± 10 years [mean ± SD]) with stable, moderate, chronic CHF (left ventricular ejection fraction 28 ± 8%) were studied in a randomized crossover trial with 8 weeks of knee extensor endurance training and 8 weeks of nontraining. The effects of the exercise-based rehabilitation were assessed in skeletal muscle metabolic capacity, exercise tolerance, and quality of life. The compliance rate in training was 98% and no adverse events occurred during the study period. Training increased the activity of citrate synthase (44%, p < 0.0001) and lactate dehydrogenase (23%, p < 0.002) in the trained muscles, and an improved oxidative capacity in relation to the glycolytic capacity (23%, p < 0.002) was found. Peak oxygen uptake (14%, p < 0.0005) and peak work rate (43%, p < 0.0001) during incremental exercise increased, and blood lactate concentration during standardized submaximal exercise and during the recovery phase decreased (17%, p < 0.05). The distance ambulated during 6 minutes (p < 0.03), and the overall (p < 0.01), physical (p < 0.05), and psychosocial (p < 0.03) health-related quality of life improved. Because the skeletal muscle endurance training improved peripheral oxidative capacity, exercise tolerance, and the health-related quality of life without any adverse events, this mode of training can be recommended for women with chronic heart failure.

References (29)

  • M Piepoli et al.

    Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Effects of physical training

    Circulation

    (1996)
  • PA Ades et al.

    Referral patterns and exercise response in the rehabilitation of female coronary patients aged over ≥62 years

    Am J Cardiol

    (1992)
  • P Andersen et al.

    Dynamic knee extension as a model for study of isolated exercising muscle in humans

    J Appl Physiol

    (1985)
  • J Bergström

    Muscle electrolytes in man

    Scan J Clin Lab Invest Suppl

    (1962)
  • Cited by (113)

    • Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7

      2022, Journal of the American College of Cardiology
      Citation Excerpt :

      In an individual-level meta-analysis of MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy), RAFT (Resynchronization–Defibrillation for Ambulatory Heart Failure Trial), and REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) performed by the U.S. Food and Drug Administration (FDA), there was a 76% reduction in HF or death (HR: 0.24; 95% CI: 0.11-0.53) from CRT-D for women with no significant benefit in men at a QRS duration between 130 and 149 milliseconds; both women and men benefited from CRT-D with a QRS duration ≥150 milliseconds.49 Additional data are needed to support and validate sex-specific target dosing of pharmacological and device therapies, surgical revascularization with coronary artery bypass grafts, and implementation of tailored exercise training with cardiac rehabilitation.50,51 Contemporary clinical trial data addressing 3 emerging and established HF therapies—sodium-glucose co-transporter-2 inhibitor (SGLT2i), angiotensin receptor-neprilysin inhibitor (ARNI) (sacubitril/valsartan), and mineralocorticoid receptor antagonists (MRA)—additionally highlight the importance of sex-specific subgroup analyses.

    View all citing articles on Scopus

    This study was supported by grants from the National Board of Health and Welfare, the Medical Research Council (No. 4494, 9515), and the Heart and Lung Foundation, Sweden.

    View full text